Search Results for "Biochemistry Leukemia"

08:10 EDT 30th October 2014 | BioPortfolio

Matching Channels

Chronic Leukemia

Chronic leukemia is a long term increase of abnormal white blood cells. It can be classed as myelogenous or lymphocytic leukemia. For more information see the Leukemia pages Add the Leukemia New...

Acute Leukemia

Acute leukemia occurs when a hematopoietic stem cell undergoes malignant transformation into a primitive, undifferentiated cell with abnormal longevity. These lymphocytes (acute lymphocytic leukemia...

Acute Myelocytic Leukemia AML

Acute myelocytic leukemia is a life-threatening disease in which the neutrophil, basophil, eosinophil, and monocyte precursors become cancerous and rapidly replace normal cells in the bone marrow. ...

Acute Lymphocytic Leukemia ALL

Acute lymphocytic leukemia (ALL) is a life-threatening disease in which the cells that normally develop into lymphocytes become cancerous and rapidly replace normal cells in the bone marrow. ALL acc...

Chronic Myelocytic Leukemia CML

Chronic myelocytic leukemia is the resulting disease when neutrophil, basophil, eosinophil, and monocyte progenitors become cancerous. It is usually caused by the presence of the Philadelphia chromo...

Matching News

UF researchers discover leukemia’s hiding places

In patients with leukemia, cancer cells can embed within the walls of blood vessels and hide from chemotherapy, according to a University of Florida study published in Leukemia. Now, UF Health researc...

New possibilities for leukemia therapy with novel mode of leukemia cell recognition

A new class of lipids in the leukemia cells that are detected by a unique group of immune cells has been discovered by researchers. By recognizing the lipids, the immune cells stimulate an immune resp...

Acute and Chronic Myelogenous Leukemia Partnering

The Acute and Chronic Myelogenous Leukemia Partnering 2009-2014 report provides understanding and access to the acute and chronic myelogenous leukemia partnering deals and agreements entered into by t...

New possibilities for leukemia therapy with a novel mode of leukemia cell recognition

(Biomedical Sciences Institutes (BMSI)) Scientists at A*STAR's Singapore Immunology Network have discovered a new class of lipids in the leukemia cells that are detected by a unique group of immune ce...

Leukemia Drugs Could Help Treat Eye Diseases

Leukemia drugs could help to improve treatments for blindness caused by abnormal blood vessel growth in the eye, finds new UCL research.R

War on leukemia: How battle for cell production could be decisive

A key step in understanding the nature of the fight for superiority between mutated genes and normal genes could lead to new therapies to combat leukemia, say researchers. The study investigated Acute...

Harnessing New Developments in Genomics to Improve Outcome for Children with Poor Prognosis Leukemia

The dramatic improvement in outcome for children with acute lymphoblastic leukemia is one of the major achievements in hematology in the last 40 years. However, while 90% of children with this disease...

Obese Children With Leukemia Fared Worse in Study

MONDAY, Oct. 27, 2014 -- Obesity may change the way young people react to chemotherapy for acute lymphoblastic leukemia, new research suggests. The study showed that obesity made young people more tha...

Matching PubMed Articles

Retraction Note: Frequency of TP53 Mutations and its Impact on Drug Sensitivity in Acute Myeloid Leukemia?

Reduction of leukemia cell burden and restoration of normal hematopoiesis at 3 months of crizotinib treatment in RAN-binding protein 2 (RANBP2)-anaplastic lymphoma kinase (ALK) acute myeloid leukemia.

Anti-proliferative activity of 6-O-acyl-d-allose against the human leukemia MOLT-4F cell line.

The anti-proliferative activities of the 6-O-acyl derivatives of d-allose against the human leukemia MOLT-4F cell line were examined. The activity of the 6-O-dodecanoyl derivative (3) was approximatel...

t(6;9)(p22;q34)/DEK-NUP214 rearranged pediatric myeloid leukemia: an international study on 62 patients.

Acute myeloid leukemia with t(6;9)(p22;q34) is listed as a distinct entity in the 2008 WHO classification, but little is known about the clinical implications of t(6;9)-positive myeloid leukemia in ch...

The characterization and role of leukemia cell-derived dendritic cells in immunotherapy for leukemic diseases.

Usually, an effective anti-leukemia immune response cannot be initiated effectively in patients with leukemia. This is probably related to immunosuppression due to chemotherapy, down-regulation of maj...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement